Titralac
Product Images NDC 55298-038

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Titralac (NDC 55298-038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Inova Pharmaceuticals Pty, Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – Bottle Label (Tit00 0000 01)

Principal Display Panel – Bottle Label (Tit00 0000 01)
This is a drug facts sheet for Titralac tablets. The active ingredient is calcium carbonate, which helps relieve heartburn, sour stomach, and acid indigestion. Users are warned to consult a doctor or pharmacist before use if they are taking any prescription drugs, as antacids may interact with them. The tablets should be chewed, swallowed, or dissolved in the mouth two tablets every two or three hours as needed, to a maximum of 19 tablets per day or two weeks. The product contains inactive ingredients such as saccharin and spearmint oil. It is manufactured in Australia for 3M and is available in a 355-10 package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.